|
| | OXOTREMORINE SESQUIFUMARATE Basic information |
| Product Name: | OXOTREMORINE SESQUIFUMARATE | | Synonyms: | OXOTREMORINE SESQUIFUMARATE SALT;bis[1-[4-(pyrrolidin-1-yl)but-2-ynyl]pyrrolidin-2-one] trifumarate;OXOTREMORINESESQUIFUARATE;1-(4-[1-Pyrrolidinyl]-2-butynyl)-2-pyrrolidinone, 1-(4-[1-Pyrrolidinyl]2-butynyl)-2-pyrrolidinone;2-Pyrrolidinone, 1-(4-(1-pyrrolidinyl)-2-butynyl)-, (E)-2-butenedioate (2:3) (9ci);2-Pyrrolidinone, 1-(4-(1-pyrrolidinyl)-2-butynyl)-, fumarate (2:3) (8ci);2-Pyrrolidinone, 1-(4-(1-pyrrolidinyl)-2-butynyl)-, sesquifumarate;Einecs 241-388-3 | | CAS: | 17360-35-9 | | MF: | C36H48N4O14 | | MW: | 760.78 | | EINECS: | 241-388-3 | | Product Categories: | | | Mol File: | 17360-35-9.mol |  |
| | OXOTREMORINE SESQUIFUMARATE Chemical Properties |
| Melting point | 102-105 °C(lit.) | | storage temp. | 2-8°C | | solubility | H2O: 50 mg/mL | | form | powder | | color | off-white |
| Hazard Codes | T+ | | Risk Statements | 26/27/28 | | Safety Statements | 28-36/37-45 | | RIDADR | UN 2811 6.1/PG 2 | | WGK Germany | 3 | | RTECS | UY6000000 | | HazardClass | 6.1(a) | | PackingGroup | I | | Toxicity | LD50 ipr-mus: 6500 mg/kg TXAPA9 28,227,1974 |
| | OXOTREMORINE SESQUIFUMARATE Usage And Synthesis |
| Uses | Oxotremorine Sesquifumarate is an M2 and M4 Muscarinic acetylcholine receptor agonist. Positive allosteric modulator used in the treatment of CNS disorders. | | Biological Activity | Muscarinic agonist. | | Biochem/physiol Actions | Oxotremorine sesquifumarate salt is a muscarinic acetylcholine receptor agonist with preference for the M2 receptor. | | Safety Profile | A poison by intraperitoneal and intravenous routes. When heated to decomposition it emits toxic vapors of NOx | | storage | Store at RT |
| | OXOTREMORINE SESQUIFUMARATE Preparation Products And Raw materials |
|
